Period of time： 2013年2期
Publisher： Future Medicine
Founded in： 2006
Total resources： 64
ISSN： 1746-0794
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Future Virology,volume 5,issue 2
Menu
Nipah and Hendra viruses: recent advances in pathogenesis
Future Virology,volume 5,issue 2 , Vol. 5, Iss. 2, 2010-03 , pp.
Access to resources
Recommend
AAV-2: how can the capsid be modified to improve the viral vector in gene therapy?
Future Virology,volume 5,issue 2 , Vol. 5, Iss. 2, 2010-03 , pp.Immunotherapy of SARS based on combinations of neutralizing human monoclonal antibodies
By Du Lanying,Jiang Shibo in (2010)
Future Virology,volume 5,issue 2 , Vol. 5, Iss. 2, 2010-03 , pp.Renin–angiotensin system in human coronavirus pathogenesis
By Wevers Brigitte A,Hoek Lia van der in (2010)
Future Virology,volume 5,issue 2 , Vol. 5, Iss. 2, 2010-03 , pp.Cross-protective responses to human papillomavirus infection
By Christensen ND,Bounds CE in (2010)
Future Virology,volume 5,issue 2 , Vol. 5, Iss. 2, 2010-03 , pp.Influenza A virus-specific CD8+ T-cell responses: from induction to function
By Olson MR,Russ BE,Doherty PC,Turner SJ,Stambas J in (2010)
Future Virology,volume 5,issue 2 , Vol. 5, Iss. 2, 2010-03 , pp.Kaposi’s sarcoma-associated herpesvirus and innate immunity
By West John A,Damania Blossom in (2010)
Future Virology,volume 5,issue 2 , Vol. 5, Iss. 2, 2010-03 , pp.Human herpesvirus 8-encoded cytokines
Future Virology,volume 5,issue 2 , Vol. 5, Iss. 2, 2010-03 , pp.By Schleiss Mark R,McVoy Michael A in (2010)
Future Virology,volume 5,issue 2 , Vol. 5, Iss. 2, 2010-03 , pp.
Previous
Next